310 results
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.4
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.3
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.2
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
16 Nov 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
kkt6w zn9luh1e94i
28 Jul 23
Departure of Directors or Certain Officers
5:10pm
8-K
EX-10.1
51a0111v05g5
6 Jul 23
Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
4:39pm
8-K
EX-10.1
i62p872b4fjx827o66n9
16 Jun 23
Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
5:24pm
8-K
EX-10.1
drvbl3tl8ht
2 Jun 23
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.2
zeost8eba 3x7tb46g
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.1
8ibrsd24ov emq
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.2
98ifxkbt6ucbpic c47l
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.4
k51ystjzvz9
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.3
l5zjr mgetr
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.1
vzi30 eo0
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.1
25rnng0 v2p0
13 Apr 23
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
5:24pm
8-K
EX-10.1
1a0vv7tm 1051uvawshu
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
8-K
EX-10.2
a3fju
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
S-8
EX-10.1
porzeoo
22 Dec 22
Registration of securities for employees
4:19pm
8-K
EX-10.1
ef7 9ohw4yjtp3hhgcn7
12 Apr 22
Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American
4:11pm